| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Open Orphan in 'advanced' talks with UK govt about challenge study
StockMarketWire.com
|
Pharmaceutical services company Open Orphan confirmed that it remained in 'advanced negotiations' with the UK government regarding a potential coronavirus challenge study.
'No contract has been signed and the company will update the market in due course as appropriate,' Open Orphan said.
Human challenge studies involve participants being intentionally infected with a pathogen to test the efficacy of a vaccine or treatment.
At 8:52am: (LON:ORPH) share price was +2p at 28.25p
Story provided by StockMarketWire.com
|
|
|
|
|
|
